Kosicka-Noworzyn K, Romaniuk-Drapala A, Sheng Y, Yohn C, Brunetti L, Kagan L
Pharmacol Rep. 2024; 76(6):1429-1442.
PMID: 39412582
PMC: 11582170.
DOI: 10.1007/s43440-024-00665-7.
Rigalli J, Gagliardi A, Diester K, Bajraktari-Sylejmani G, Blank A, Burhenne J
Int J Mol Sci. 2024; 25(7).
PMID: 38612927
PMC: 11012658.
DOI: 10.3390/ijms25074118.
Gao Y, Deng H, Zhao Y, Li M, Wang L, Zhang Y
Toxics. 2024; 12(1).
PMID: 38251011
PMC: 10818656.
DOI: 10.3390/toxics12010055.
Bucci-Munoz M, Gola A, Rigalli J, Ceballos M, Ruiz M
Life (Basel). 2023; 13(8).
PMID: 37629489
PMC: 10455762.
DOI: 10.3390/life13081633.
Shi Q, Yuan X, Zeng Y, Wang J, Zhang Y, Xue C
Nutrients. 2023; 15(10).
PMID: 37242293
PMC: 10222613.
DOI: 10.3390/nu15102411.
Molecular and Clinical Links between Drug-Induced Cholestasis and Familial Intrahepatic Cholestasis.
Vitale G, Mattiaccio A, Conti A, Berardi S, Vero V, Turco L
Int J Mol Sci. 2023; 24(6).
PMID: 36982896
PMC: 10057459.
DOI: 10.3390/ijms24065823.
4-Phenylbutyrate protects against rifampin-induced liver injury via regulating MRP2 ubiquitination through inhibiting endoplasmic reticulum stress.
Chen J, Wu H, Tang X, Chen L
Bioengineered. 2022; 13(2):2866-2877.
PMID: 35045794
PMC: 8974152.
DOI: 10.1080/21655979.2021.2024970.
Physiologically Based Pharmacokinetic Modelling of Cabozantinib to Simulate Enterohepatic Recirculation, Drug-Drug Interaction with Rifampin and Liver Impairment.
Gerner B, Scherf-Clavel O
Pharmaceutics. 2021; 13(6).
PMID: 34067429
PMC: 8224782.
DOI: 10.3390/pharmaceutics13060778.
In Vitro Stimulation of Multidrug Resistance-Associated Protein 2 Function Is Not Reproduced In Vivo in Rats.
Gilibili R, Kurawattimath V, Murali B, Lai Y, Mariappan T, Shen H
Pharmaceutics. 2018; 10(3).
PMID: 30096834
PMC: 6161027.
DOI: 10.3390/pharmaceutics10030125.
Effect of doxycycline and probiotics on mRNA expression of ABCC2 in small intestines of chickens.
Milanova A, Pavlova I, Yordanova V, Danova S
Iran J Vet Res. 2017; 17(4):265-267.
PMID: 28224011
PMC: 5309459.
CFTR-associated ligand is a negative regulator of Mrp2 expression.
Li M, Soroka C, Harry K, Boyer J
Am J Physiol Cell Physiol. 2016; 312(1):C40-C46.
PMID: 27834195
PMC: 5283898.
DOI: 10.1152/ajpcell.00100.2016.
Regulation of multidrug resistance proteins by genistein in a hepatocarcinoma cell line: impact on sorafenib cytotoxicity.
Rigalli J, Ciriaci N, Arias A, Ceballos M, Villanueva S, Luquita M
PLoS One. 2015; 10(3):e0119502.
PMID: 25781341
PMC: 4364073.
DOI: 10.1371/journal.pone.0119502.
Gene replacement therapy for genetic hepatocellular jaundice.
van Dijk R, Beuers U, Bosma P
Clin Rev Allergy Immunol. 2014; 48(2-3):243-53.
PMID: 25315738
DOI: 10.1007/s12016-014-8454-7.
ABCC3 as a marker for multidrug resistance in non-small cell lung cancer.
Zhao Y, Lu H, Yan A, Yang Y, Meng Q, Sun L
Sci Rep. 2013; 3:3120.
PMID: 24176985
PMC: 3814586.
DOI: 10.1038/srep03120.
An In Silico Classification Model for Putative ABCC2 Substrates.
Pinto M, Trauner M, Ecker G
Mol Inform. 2012; 31(8):547-553.
PMID: 23198001
PMC: 3505902.
DOI: 10.1002/minf.201200049.
Multidrug resistance associated proteins in multidrug resistance.
Sodani K, Patel A, Kathawala R, Chen Z
Chin J Cancer. 2011; 31(2):58-72.
PMID: 22098952
PMC: 3777468.
DOI: 10.5732/cjc.011.10329.
Expression, localization and polymorphisms of the nuclear receptor PXR in Barrett's esophagus and esophageal adenocarcinoma.
van de Winkel A, Menke V, Capello A, Moons L, Pot R, van Dekken H
BMC Gastroenterol. 2011; 11:108.
PMID: 21977915
PMC: 3204292.
DOI: 10.1186/1471-230X-11-108.
Differences in the disposition of silymarin between patients with nonalcoholic fatty liver disease and chronic hepatitis C.
Schrieber S, Hawke R, Wen Z, Smith P, Reddy K, Wahed A
Drug Metab Dispos. 2011; 39(12):2182-90.
PMID: 21865319
PMC: 3226378.
DOI: 10.1124/dmd.111.040212.
ABCC multidrug transporters in childhood neuroblastoma: clinical and biological effects independent of cytotoxic drug efflux.
Henderson M, Haber M, Porro A, Munoz M, Iraci N, Xue C
J Natl Cancer Inst. 2011; 103(16):1236-51.
PMID: 21799180
PMC: 3156802.
DOI: 10.1093/jnci/djr256.
Multidrug resistance proteins (MRPs/ABCCs) in cancer chemotherapy and genetic diseases.
Chen Z, Tiwari A
FEBS J. 2011; 278(18):3226-45.
PMID: 21740521
PMC: 3168698.
DOI: 10.1111/j.1742-4658.2011.08235.x.